Month: March 2024

GINSMS Announces Audited Financial Results for the Twelve-Month Period Ended December 31, 2023

Written by Customer Service on March 27, 2024. Posted in Public Companies.

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) — GINSMS Inc. (TSXV: GOK) (the “Corporation” or “GINSMS”) is pleased to announce that its audited financial statements for the twelve-month period ended December 31, 2023 have been filed today on SEDAR and are available at www.sedar.com. On February 13, 2024, GINSMS had disclosed through the issuance of a press release unaudited financial results for the three-month and the twelve-month periods ended December 31, 2023 and provided financial forecasts for the 2024 financial year. This financial disclosure was done in advance of today’s filing of the audited financial statements of the Corporation to allow GINSMS’ ultimate holding company, Beat Holdings Limited (“BHL”), a public company in Japan, to use certain of GINSMS’ financial information in the preparation of BHL’s financial...

Navigator Gas Announces Availability of its Annual Report on Form 20-F for the Year Ended December 31, 2023

Written by Customer Service on March 27, 2024. Posted in Public Companies.

LONDON, March 27, 2024 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces that it has filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission. Form 20-F can be downloaded using the link below and is available on our website (www.navigatorgas.com) in the ‘Investors Centre’ section under ‘Financials’ then ‘SEC Filings’. Shareholders may request a hard copy at no cost using the contact details listed below. 2023 Form 20-F Annual Report About Navigator GasNavigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) is the owner and operator of the world’s largest fleet of handysize liquefied...

Draganfly Reports its 2023 Results

Written by Customer Service on March 27, 2024. Posted in Public Companies.

Saskatoon, SK., March 27, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its fourth quarter and fiscal 2023 financial results. Revenue for the fourth quarter and the year was dictated by the shift to larger in-house capacity and drone production capabilities. The financial year 2023 was a transition year for Draganfly as 2023 marked new production capacity coming online along with the commercialization of its flagship Commander 3XL and Heavy Lift Drone platforms. Key Financial Highlights for 2023:‎Total revenue for the year ended December 31, 2023, was $6,554,842. Product sales decreased $263,339 in 2023 as compared to 2022, while services revenue decreased $786,878. This...

CORRECTION – Vocodia Announces Founder and Management Team Investments in Company IPO

Written by Customer Service on March 27, 2024. Posted in Public Companies.

In a release issued under the same headline yesterday, March 26th, please note that the date of Vocodia’s IPO completion should be February 26th, not February 22nd, as previously stated. The corrected release follows: CHICAGO, March 27, 2024 (GLOBE NEWSWIRE) — Vocodia Holdings Corp. (CBOE: VHAI) (“Vocodia” or the “Company”), an AI software company that builds practical AI functions, today announced that the Company’s senior management team invested in Vocodia’s Initial Public Offering (“IPO”) that was completed on February 26, 2024. Brian Podolak, Co-Founder, Chief Executive Officer and Director of Vocodia, invested $400,000 through the purchase of 94,117 units of the IPO. James Sposato, Co-Founder, Chief Technology Officer and Director, and Scott Silverman, Chief Financial Officer, also participated...

FlexShopper, Inc. Schedules 2023 Fourth Quarter and Year End Financial Results Conference Call

Written by Customer Service on March 27, 2024. Posted in Public Companies.

Conference Call Scheduled for Tuesday, April 2, 2024, at 8:30 a.m. ET BOCA RATON, Fla., March 27, 2024 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer and payment solution provider for underserved consumers, announced today that it intends to release its financial results for its fourth quarter and year end ended December 31, 2023, after the market closes on Monday, April 1, 2024. The Company intends to hold a conference call to discuss those results the next day, April 2 at 8:30 a.m. Eastern Time. Conference Call DetailsDate: Tuesday, April 2, 2024Time: 8:30 a.m. Eastern Time Participant Dial-In Numbers:Domestic callers: 877-407-2988International callers: 201-389-0923Access by Webcast The call will also be simultaneously webcast...

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

Written by Customer Service on March 27, 2024. Posted in Earnings Releases And Operating Results.

CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update. “2024 will prove to be a critical year for Vaxxinity as we refocus our efforts on our neurodegeneration programs and move closer to obtaining our company’s first approval,” said Mei Mei Hu, CEO of Vaxxinity. “Just this month, we presented exploratory biomarker data from our Phase 1 trial of UB-312 in Parkinson’s patients: a first of its kind demonstrating target engagement of toxic alpha-synuclein in the CNS and a potential correlation with clinical efficacy. This represents a major step for our platform in neurodegeneration where...

Super League Announces Fourth Quarter and Full Year 2023 Financial Results

Written by Customer Service on March 27, 2024. Posted in Earnings Releases And Operating Results.

~ Fourth Quarter Revenues Increase 34% Year-over-Year to a Company Record $9.5 Million ~ ~ Full Year Revenues Increase 27% Year-over-Year to a Company Record $25.1 Million ~ SANTA MONICA, Calif., March 27, 2024 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), a leading creator and publisher of content experiences and media solutions across the world’s largest immersive platforms, has released its fourth quarter and full year 2023 financial results in the form of a shareholder letter. A webinar hosted by Ann Hand, CEO of Super League, and Clayton Haynes, CFO of Super League, will be streamed here beginning today, Wednesday, March 27, 2024 at 5:00 PM Eastern Time to further discuss the results. Management Commentary by Chief Executive Officer, Ann Hand: “Significant operational initiatives led 2023 to be a foundational...

Announcement for the Purposes of Rule 2.12 of the Irish Takeover Rules

Written by Customer Service on March 27, 2024. Posted in Public Companies.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. BURLINGTON, Mass., March 27, 2024 (GLOBE NEWSWIRE) — Further to the announcement made by Progress Software Corp. (“Progress”) under Rule 2.4 of the Irish Takeover Rules on March 26, 2024, Progress confirms for the purposes of Rule 2.12 of the Irish Takeover Rules that any offer by Progress for MariaDB plc (“MariaDB”) is, or is likely to be, solely in cash. Accordingly, there are no disclosure requirements under Rule 8.1, Rule 8.2 and Rule 8.3 of the Irish Takeover Rules in relation to relevant securities of Progress. There can be no certainty that an offer will be made, or as to the terms on which any offer might be made. A further announcement...

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

Written by Customer Service on March 27, 2024. Posted in Earnings Releases And Operating Results.

Initiated enrollment of the BACKBEAT global pivotal study evaluating AVIM therapy (also known as BackBeat Cardiac Neuromodulation Therapy) in hypertensive pacemaker patients in collaboration with Medtronic, plc (NYSE: MDT) in December 2023 Orchestra BioMed and Terumo remain actively engaged to update operational plans and financial arrangements for Virtue® Sirolimus AngioInfusionTM Balloon (“SAB”) development and commercialization for treatment of coronary and peripheral artery disease Expected runway of cash and cash equivalents and marketable securities, including certain potential future proceeds sufficient into 2H 2026, beyond anticipated BACKBEAT top-line results readoutNEW HOPE, Pa., March 27, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company...

Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity

Written by Customer Service on March 27, 2024. Posted in Earnings Releases And Operating Results.

Company to host conference call on Thursday, March 28, 2024 at 8:00 a.m. ET BOSTON and ATLANTA, March 27, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease (“PD”), Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases, today reported financial results for the fourth quarter and full year ended December 31, 2023 and highlighted recent developments. “2023 was a year of clinical execution across our pipeline, culminating in the recent pre-NDA meeting with the FDA for IkT-001Pro and robust enrollment of untreated Parkinson’s patients in our 201 Trial evaluating Risvodetinib (“Risvo”),” said Dr. Milton H. Werner, President and Chief...

Month: March 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals